Skip to main content

. 1995 May;58(5):639–640. doi: 10.1136/jnnp.58.5.639

Kava and dopamine antagonism.

L Schelosky, C Raffauf, K Jendroska, W Poewe

PMCID: PMC1073504 PMID: 7745421

639

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Cawte J. Psychoactive substances of the South Seas: betel, kava and pituri. Aust N Z J Psychiatry. 1985 Mar;19(1):83–87. doi: 10.3109/00048678509158818. [DOI] [PubMed] [Google Scholar]
Davies L. P., Drew C. A., Duffield P., Johnston G. A., Jamieson D. D. Kava pyrones and resin: studies on GABAA, GABAB and benzodiazepine binding sites in rodent brain. Pharmacol Toxicol. 1992 Aug;71(2):120–126. doi: 10.1111/j.1600-0773.1992.tb00530.x. [DOI] [PubMed] [Google Scholar]
Jamieson D. D., Duffield P. H., Cheng D., Duffield A. M. Comparison of the central nervous system activity of the aqueous and lipid extract of kava (Piper methysticum). Arch Int Pharmacodyn Ther. 1989 Sep-Oct;301:66–80. [PubMed] [Google Scholar]
Singh Y. N. Kava: an overview. J Ethnopharmacol. 1992 Aug;37(1):13–45. doi: 10.1016/0378-8741(92)90003-a. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES